ALZN - Alzamend Neuro, Inc.
1.98
0.030 1.515%
Share volume: 29,977
Last Updated: 03-06-2026
Pharmaceutical Products/Pharmaceutical Preparations:
3.14%
PREVIOUS CLOSE
CHG
CHG%
$1.95
0.03
0.02%
View ratios
| Fiscal Date | 01-31-2024 | 04-30-2024 | 07-31-2024 | 10-31-2024 | |
|---|---|---|---|---|---|
| Fiscal Quarter | Q3 2024 | Q4 2024 | Q1 2024 | Q2 2024 | |
| Report Date | 03-25-2024 | 07-22-2025 | 09-11-2024 | 12-11-2024 | |
| Cash flow financing | 2.114 M | -5.299 M | 1.964 M | 8.263 M | |
| Other financing cash flows | 0.000 | 0.000 | 0.000 | 0.000 | |
| Cash flow | 0.000 | -7.747 M | 817.902 K | 7.162 M | |
| Net income | -2.662 M | -4.019 M | -974.411 K | -1.362 M | |
| Depreciation | 12.685 K | 12.685 K | 12.685 K | 12.685 K | |
| Changes in inventories | 0.000 | 0.000 | 0.000 | 0.000 | |
| Changes in receivables | 0.000 | 0.000 | 0.000 | 0.000 | |
| Investing Cashflow | 0.000 | -57.243 K | -90.000 K | 57.243 K | |
| Net Borrowings | 0.000 | 0.000 | 0.000 | 0.000 | |
| Investing Activity Other | 0.000 | 0.000 | 0.000 | 0.000 | |
| Dividends Paid | 0.000 | 0.000 | 0.000 | 0.000 | |
| Exchange Rate Effect | 0.000 | 0.000 | 0.000 | 0.000 | |
| Capital Expenditures | 0.000 | 57.243 K | 90.000 K | -57.243 K | |
| Cash Change | 82.788 K | -7.747 M | 817.902 K | 7.162 M |